Skip to content

Oral Versus Intravenous Acetaminophen for Postoperative Pain Control

Oral Versus Intravenous Acetaminophen for Postoperative Pain Management After Oocyte Retrieval Procedure. A Double Blinded, Placebo Controlled, Randomized Clinical Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04662567
Enrollment
42
Registered
2020-12-10
Start date
2021-03-12
Completion date
2021-09-05
Last updated
2022-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IVF, Postoperative Pain

Keywords

oocyte retrieval, postoperative pain control, in vitro fertilization, tylenol

Brief summary

The investigators are going to study the difference in postoperative pain control after administration of oral versus intravenous formulation of acetaminophen

Detailed description

Oocyte retrieval is an outpatient procedure that is a routine surgical intervention in the process of assisted reproductive technologies and oocyte banking. The perioperative pain control is achieved with multidrug regimen including intraoperative opioid medication and perioperative administration of oral or intravenous acetaminophen. This medication is more commonly known as Tylenol. Intravenous formulation of this medication is several fold more expensive and the data for perioperative pain control is mixed on the equivalence of pain control with intravenous versus oral acetaminophen in other fields. Currently there is no accepted standard of care and the two formulations are used interchangeably depending on primary physician's preference. We are conducting an equivalence placebo controlled randomized clinical trial to assess the difference in efficacy of these two formulations

Interventions

DRUGacetaminophen

compare the postoperative pain 1 hour and \ 24h post surgery

Sponsors

Northwell Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. Provision of signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. Female, aged 18-45 4. Ability to take oral medication and be willing to adhere to the study intervention regimen

Exclusion criteria

1. Known clinically significant liver disfunction 2. Known allergic reactions to components of acetaminophen such as angioedema, anaphylaxis or other 3. Known current substance use disorder 4. Chronic pain syndrome 5. Weight less than 50 kg

Design outcomes

Primary

MeasureTime frameDescription
postoperative pain control24-48 hoursTo compare the efficacy of oral versus IV formulation of acetaminophen for controlling perioperative pain after oocyte retrieval procedure. To assess the pain level, Visual Analog Scale(VAS) score will be utilize with the minimum number 0 representing no pain and maximum number of 10 representing the highest imaginable pain level.

Secondary

MeasureTime frameDescription
Duration of postoperative recoveryvariable ~1-3 hoursTo compare time from the end of procedure until discharge. This outcome is measured in minutes from the the time of entry to recovery room to the time when patient is leaving the facility

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026